420 related articles for article (PubMed ID: 1356444)
21. The cleavage of plasmenylethanolamine by phospholipase A2 appears to be mediated by the low affinity binding site of the TxA2/PGH2 receptor in U46619-stimulated human platelets.
Turini ME; Holub BJ
Biochim Biophys Acta; 1994 Jun; 1213(1):21-6. PubMed ID: 8011675
[TBL] [Abstract][Full Text] [Related]
22. Identification of Gq as one of the G-proteins which copurify with human platelet thromboxane A2/prostaglandin H2 receptors.
Knezevic I; Borg C; Le Breton GC
J Biol Chem; 1993 Dec; 268(34):26011-7. PubMed ID: 8245033
[TBL] [Abstract][Full Text] [Related]
23. Kinetic studies on stereospecific recognition by the thromboxane A2/prostaglandin H2 receptor of the antagonist, S-145.
Kishino J; Hanasaki K; Nagasaki T; Arita H
Br J Pharmacol; 1991 Aug; 103(4):1883-8. PubMed ID: 1833018
[TBL] [Abstract][Full Text] [Related]
24. Binding characteristics of the new thromboxane A2/prostaglandin H2 receptor antagonist [3H]BAY U 3405 to washed human platelets and platelet membranes.
Theis JG; Dellweg H; Perzborn E; Gross R
Biochem Pharmacol; 1992 Aug; 44(3):495-503. PubMed ID: 1387312
[TBL] [Abstract][Full Text] [Related]
25. Antiaggregatory activity of 8-epi-prostaglandin F2 alpha and other F-series prostanoids and their binding to thromboxane A2/prostaglandin H2 receptors in human platelets.
Yin K; Halushka PV; Yan YT; Wong PY
J Pharmacol Exp Ther; 1994 Sep; 270(3):1192-6. PubMed ID: 7932171
[TBL] [Abstract][Full Text] [Related]
26. Characteristics of the binding of [3H]-mepyramine to intact human U373 MG astrocytoma cells: evidence for histamine-induced H1-receptor internalisation.
Hishinuma S; Young JM
Br J Pharmacol; 1995 Nov; 116(6):2715-23. PubMed ID: 8590995
[TBL] [Abstract][Full Text] [Related]
27. Heterogeneity of prostaglandin H2/thromboxane A2 receptors: distinct subtypes mediate vascular smooth muscle contraction and platelet aggregation.
Furci L; Fitzgerald DJ; Fitzgerald GA
J Pharmacol Exp Ther; 1991 Jul; 258(1):74-81. PubMed ID: 1830100
[TBL] [Abstract][Full Text] [Related]
28. Pharmacology of [3H]-pyrilamine binding and of the histamine-induced inositol phosphates generation, intracellular Ca2+ -mobilization and cytokine release from human corneal epithelial cells.
Sharif NA; Wiernas TK; Griffin BW; Davis TL
Br J Pharmacol; 1998 Nov; 125(6):1336-44. PubMed ID: 9863665
[TBL] [Abstract][Full Text] [Related]
29. Dihydropyridine agonist Bay K 8644 inhibits platelet activation by competitive antagonism of thromboxane A2-prostaglandin H2 receptor.
Johnson GJ; Dunlop PC; Leis LA; From AH
Circ Res; 1988 Mar; 62(3):494-505. PubMed ID: 2449295
[TBL] [Abstract][Full Text] [Related]
30. Characterization of thromboxane A2/prostaglandin H2 receptors in human vascular smooth muscle cells.
Morinelli TA; Mais DE; Oatis JE; Crumbley AJ; Halushka PV
Life Sci; 1990; 46(24):1765-72. PubMed ID: 2141663
[TBL] [Abstract][Full Text] [Related]
31. Characterization of thromboxane A2/prostaglandin H2 receptors in porcine coronary artery--the inhibitory effect of a novel dibenzoxepin derivative, KW-3635.
Miki I; Ishii A
Thromb Haemost; 1992 May; 67(5):582-4. PubMed ID: 1387741
[TBL] [Abstract][Full Text] [Related]
32. Polymyxin B increases TXA2/PGH2 agonist and antagonist affinities in human platelet membranes.
Halushka PV; Boehm A; Mais DE
Eicosanoids; 1988; 1(1):41-4. PubMed ID: 2856171
[TBL] [Abstract][Full Text] [Related]
33. Thromboxane A2-mediated shape change: independent of Gq-phospholipase C--Ca2+ pathway in rabbit platelets.
Ohkubo S; Nakahata N; Ohizumi Y
Br J Pharmacol; 1996 Mar; 117(6):1095-104. PubMed ID: 8882602
[TBL] [Abstract][Full Text] [Related]
34. Effect of specific phospholipid molecular species incorporated in human platelet membranes on thromboxane A2/prostaglandin H2 receptors.
Bayon Y; Croset M; Daveloose D; Guerbette F; Chirouze V; Viret J; Kader JC; Lagarde M
J Lipid Res; 1995 Jan; 36(1):47-56. PubMed ID: 7706947
[TBL] [Abstract][Full Text] [Related]
35. In vivo and in vitro interaction of the novel selective histamine H1 receptor antagonist mizolastine with H1 receptors in the rodent.
Benavides J; Schoemaker H; Dana C; Claustre Y; Delahaye M; Prouteau M; Manoury P; Allen J; Scatton B; Langer SZ
Arzneimittelforschung; 1995 May; 45(5):551-8. PubMed ID: 7612054
[TBL] [Abstract][Full Text] [Related]
36. Binding of an 125I-labeled thromboxane A2/prostaglandin H2 receptor antagonist to washed canine platelets.
Mais DE; Kochel PJ; Saussy DL; Halushka PV
Mol Pharmacol; 1985 Aug; 28(2):163-9. PubMed ID: 2991736
[TBL] [Abstract][Full Text] [Related]
37. Binding of a thromboxane A2/prostaglandin H2 receptor antagonist to washed human platelets.
Mais DE; Burch RM; Saussy DL; Kochel PJ; Halushka PV
J Pharmacol Exp Ther; 1985 Dec; 235(3):729-34. PubMed ID: 3001275
[TBL] [Abstract][Full Text] [Related]
38. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor.
Yu SM; Wu TS; Teng CM
Br J Pharmacol; 1994 Mar; 111(3):906-12. PubMed ID: 8019768
[TBL] [Abstract][Full Text] [Related]
39. Correlation of histamine H1 receptor function and [3H]mepyramine binding in porcine tracheal tissue.
Driver AG; Mustafa SJ
Eur J Pharmacol; 1987 Jul; 139(3):287-95. PubMed ID: 3666006
[TBL] [Abstract][Full Text] [Related]
40. Evidence for functional thromboxane A2-prostaglandin H2 receptors in human placenta.
Hedberg A; Mento PF; Liu EC; Hollander AM; Wilkes BM
Am J Physiol; 1989 Feb; 256(2 Pt 1):E256-63. PubMed ID: 2521985
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
